|
|
Volumn 185, Issue 2, 2001, Pages 119-122
|
|
Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis
|
|
Author keywords
Chronic inflammatory demyelinating polyneuropathy; Inclusion body myositis; Myasthenia gravis; Mycophenolate; Polymyositis; Therapy
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
IMMUNOGLOBULIN;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
PYRIDOSTIGMINE;
ABDOMINAL PAIN;
ADULT;
AGED;
ARTICLE;
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
CLINICAL ARTICLE;
DRUG EFFICACY;
FEMALE;
HUMAN;
HYPERTENSION;
INCLUSION BODY MYOSITIS;
INSOMNIA;
LONG TERM EXPOSURE;
MALE;
MUSCLE STRENGTH;
MYASTHENIA GRAVIS;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RELAPSE;
TREMOR;
VERTIGO;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS;
CHRONIC DISEASE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MYASTHENIA GRAVIS;
MYCOPHENOLIC ACID;
MYOSITIS, INCLUSION BODY;
POLYNEUROPATHIES;
PREDNISONE;
TREATMENT OUTCOME;
|
|
EID: 0035310730
PISSN: 0022510X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-510X(01)00478-6 Document Type: Article |
|
Times cited : (124)
|
|
References (10)
|
